Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada.

BACKGROUND The prevalence of cannabis use in HIV-infected individuals is high and its long-term effects are unclear. METHODS The prevalence, perceived benefits and consequences, and predictors of cannabis use were studied using a cross-sectional survey in two immunodeficiency clinics in Maritime Canada. RESULTS Current cannabis use was identified in 38.5% (87 of 226) of participants. Almost all cannabis users (85 of 87 [97.7%]) acknowledged its use for recreational purposes, with 21.8% (19 of 87) reporting medicinal cannabis use. The majority of patients enrolled in the present study reported mild or no symptoms related to HIV (n=179). Overall, 80.5% (70 of 87) of the cannabis-using participants reported a symptom-relieving benefit, mostly for relief of stress, anorexia or pain. Participants consumed a mean (± SD) of 18.3±21.1 g of cannabis per month and spent an average of $105.15±109.87 on cannabis per month. Cannabis use was associated with rural residence, lower income level, driving under the influence of a substance, and consumption of ecstasy and tobacco. Income level, ecstasy use and tobacco use were retained as significant predictors in regression modelling. Cannabis use was not associated with adverse psychological outcomes. DISCUSSION Prolonged previous cannabis consumption and the substantial overlap between recreational and medicinal cannabis use highlight the challenges in obtaining a tenable definition of medicinal cannabis therapy.

[1]  M. Asbridge,et al.  Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis , 2012, BMJ : British Medical Journal.

[2]  A. Ferketich,et al.  Cigarette smoking in the HIV-infected population. , 2011, Proceedings of the American Thoracic Society.

[3]  G. Elwyn,et al.  Tough decisions faced by people living with HIV: a literature review of psychosocial problems. , 2010, AIDS reviews.

[4]  Wayne Hall,et al.  Adverse health effects of non-medical cannabis use , 2009, The Lancet.

[5]  E. Quoix.  [What is new in the epidemiology of lung cancer: non-smokers, women and the role of cannabis?]. , 2009, La Revue du praticien.

[6]  James Poling,et al.  The effect of cannabis compared with alcohol on driving. , 2009, The American journal on addictions.

[7]  A. Reece.  Chronic toxicology of cannabis , 2009, Clinical toxicology.

[8]  S. Nahvi,et al.  Review: the need for smoking cessation among HIV-positive smokers. , 2009, AIDS education and prevention : official publication of the International Society for AIDS Education.

[9]  W. Vollmer,et al.  Marijuana and chronic obstructive lung disease: a population-based study , 2009, Canadian Medical Association Journal.

[10]  F. Vaida,et al.  Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial , 2009, Neuropsychopharmacology.

[11]  M. Ranganathan,et al.  Cannabinoids and psychosis , 2009, International review of psychiatry.

[12]  J. Rabkin.  HIV and depression: 2008 review and update , 2008, Current HIV/AIDS reports.

[13]  J. Collet,et al.  Adverse effects of medical cannabinoids: a systematic review , 2008, Canadian Medical Association Journal.

[14]  M. Lemstra,et al.  A meta-analysis of marijuana and alcohol use by socio-economic status in adolescents aged 10-15 years. , 2008, Canadian journal of public health = Revue canadienne de sante publique.

[15]  R. Mechoulam,et al.  Cannabinoids in health and disease , 2007, Dialogues in clinical neuroscience.

[16]  A. Hathaway,et al.  Barriers to access to medical cannabis for Canadians living with HIV/AIDS , 2007, AIDS care.

[17]  S. Leatherdale,et al.  Marijuana and tobacco use among young adults in Canada: are they smoking what we think they are smoking? , 2007, Cancer Causes & Control.

[18]  A. Smith,et al.  Cannabis use, cognitive performance and mood in a sample of workers , 2006, Journal of psychopharmacology.

[19]  M. Woodward,et al.  Marijuana use and car crash injury. , 2005, Addiction.

[20]  W. Schlenger,et al.  High prevalence of substance use disorders among adolescents who use marijuana and inhalants. , 2005, Drug and alcohol dependence.

[21]  J. Rabkin,et al.  Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood , 2005, Psychopharmacology.

[22]  M. Gill,et al.  Changing mortality rates and causes of death for HIV‐infected individuals living in Southern Alberta, Canada from 1984 to 2003 , 2005, HIV medicine.

[23]  S. Walmsley,et al.  Medicinal and recreational marijuana use by patients infected with HIV. , 2004, AIDS patient care and STDs.

[24]  D. Israelski,et al.  Patterns of Marijuana Use Among Patients With HIV/AIDS Followed in a Public Health Care Setting , 2004, Journal of acquired immune deficiency syndromes.

[25]  C. Newton,et al.  Microbial Infections, Immunomodulation, and Drugs of Abuse , 2003, Clinical Microbiology Reviews.

[26]  J. Singer,et al.  Cannabis Use by Persons Living with HIV/AIDS: Patterns and Prevalence of Use , 2003 .

[27]  S. Bagshaw,et al.  Medical Efficacy of Cannabinoids and Marijuana: A Comprehensive Review of the Literature , 2002, Journal of palliative care.

[28]  G. Bovasso.  Cannabis abuse as a risk factor for depressive symptoms. , 2001, The American journal of psychiatry.

[29]  D. Yurgelun-Todd,et al.  Neuropsychological performance in long-term cannabis users. , 2001, Archives of general psychiatry.

[30]  S. Sidney.  Marijuana Use in HIV-Positive and AIDS Patients , 2001 .

[31]  R. Hogg,et al.  Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. , 2001, AIDS.

[32]  W. Hall,et al.  The effects of adolescent cannabis use on educational attainment: a review. , 2000, Addiction.

[33]  J. Brook,et al.  The risks for late adolescence of early adolescent marijuana use. , 1999, American journal of public health.

[34]  J. Timpone,et al.  The Safety and Pharmacokinetics of Single-Agent and Combination Therapy with Megestrol Acetate and Dronabinol for the Treatment of HIV Wasting Syndrome , 1997 .

[35]  K. Shepard,et al.  Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. , 1995, Journal of pain and symptom management.

[36]  C. Geiger,et al.  Effect of Dronabinol on Nutritional Status in HIV Infection , 1993, The Annals of pharmacotherapy.

[37]  D. Dansak.  Medical use of recreational drugs by AIDS patients. , 1997, Journal of addictive diseases.